Yeo Kyeoung Kim

Ontology type: schema:Person     

Person Info


Yeo Kyeoung



Publications in SciGraph latest 50 shown

  • 2017-09 The clonal origins of leukemic progression of myelodysplasia in LEUKEMIA
  • 2016-12 Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen in BMC CANCER
  • 2016-10 Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression in ANNALS OF HEMATOLOGY
  • 2016-03 Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML in ANNALS OF HEMATOLOGY
  • 2016-02 Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression in LEUKEMIA
  • 2016-01 Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2016-01 Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2016-01 Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry in ANNALS OF HEMATOLOGY
  • 2016-01 Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen in ANNALS OF HEMATOLOGY
  • 2015-12 Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma in BMC CANCER
  • 2014-11 Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-08 Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-05 Decreased body mass index is associated with poor prognosis in patients with multiple myeloma in ANNALS OF HEMATOLOGY
  • 2014-01 The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea in ANNALS OF HEMATOLOGY
  • 2013-06 Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial in ANNALS OF HEMATOLOGY
  • 2013-06 Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-04 Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era in ANNALS OF HEMATOLOGY
  • 2013-03 Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-02 KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement in ANNALS OF HEMATOLOGY
  • 2013-01 Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-09 Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-07 A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma in ANNALS OF HEMATOLOGY
  • 2012-06 Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients in MEDICAL ONCOLOGY
  • 2012-06 High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia in BRITISH JOURNAL OF CANCER
  • 2012-01 Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2011-12 Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins in ANNALS OF HEMATOLOGY
  • 2011-11 Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia in ANNALS OF HEMATOLOGY
  • 2011-07 Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2011-02 Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2010-08 Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors in ANNALS OF HEMATOLOGY
  • 2010-08 Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells in ANNALS OF HEMATOLOGY
  • 2010-07 Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment in ANNALS OF HEMATOLOGY
  • 2010-05 Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study in ANNALS OF HEMATOLOGY
  • 2010-05 Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP) in ANNALS OF HEMATOLOGY
  • 2009-11 Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens in ANNALS OF HEMATOLOGY
  • 2009-07 Polymyositis and myocarditis after donor lymphocyte infusion in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2009-05 The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma in ANNALS OF HEMATOLOGY
  • 2007-10 Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma in LEUKEMIA
  • 2006-04 Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients in ANNALS OF HEMATOLOGY
  • 2004-11 Nonmyeloablative stem cell transplantation following a cytoreductive autograft in patients with non-Hodgkin's lymphoma who relapse after autologous transplantation in BONE MARROW TRANSPLANTATION
  • 2003-11 Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • 2003-02 Increased inducible nitric oxide synthase expression and nitric oxide concentration in patients with aplastic anemia in ANNALS OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Kim", 
        "givenName": "Yeo Kyeoung", 
        "id": "sg:person.01357201730.48", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:02", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_729.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    Preview window. Press ESC to close (or click here)